New insights from diverse population data to be presented at AMCP and ISPOR

Inovalon will present new research utilizing data from one of the largest healthcare datasets in the US.

Go to the profile of Freya Leask
Apr 09, 2019
0
0

Inovalon (MD, USA) will present new research powered by its Medical Outcomes Research for Effectiveness and Economics Registry (MORE2 Registry®), one of the USA’s largest and most comprehensive healthcare data sets, at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting (25–28 March, San Diego, CA, USA) and the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meeting (18–22 May, New Orleans, LA, USA).

“The results being presented highlight the real challenges that health plans and providers have in serving diverse healthcare populations,” said John E. Linnehan, director of the Health Economics & Advanced Analytics practice at Avalere Health, an Inovalon company. “The challenges and opportunities identified in these studies will support targeted initiatives to improve quality outcomes for patients, and the success of our clients working to serve them.”

The MORE2 Registry® covers data from more than 264 million unique patients and 42 billion medical events across Medicare fee-for-service, Medicare Part D, Medicare Advantage, managed Medicaid and commercially-insured patients. It is currently being used to power machine learning and artificial intelligence development as well as real-time healthcare decision making.

Source: https://www.inovalon.com/news/inovalon-data-powers-new-insights-on-diverse-healthcare-populations/

Go to the profile of Freya Leask

Freya Leask

Publisher, Future Science Group

I am the Publisher of RegMedNet, 3DMedNet, RxNet and The Evidence Base, here to help users make the most of the websites and build our expert communities. I am passionate about digital and STM publishing, social media and story-telling. Please get in touch if you have any queries or comments!
13 Contributions
2 Followers
2 Following

No comments yet.